Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Lymphoma, Non-Hodgkin 6Lymphoma, B-Cell 5Recurrence 4Burkitt Lymphoma 4Neoplasm, Residual 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, Follicular 3Lymphoma 3Leukemia, Myeloid, Acute 3Leukemia 3Multiple Myeloma 2Lymphoma, Mantle-Cell 2Leukemia, Lymphocytic, Chronic, B-Cell 2Glioma 2Glioblastoma 2Colorectal Neoplasms 2Carcinoma, Hepatocellular 2Breast Neoplasms 2Stomach Neoplasms 1Solid Tumors 1Simpson-Golabi-Behmel syndrome 1Sarcoma, Synovial 1Sarcoma, Ewing 1Sarcoma 1Rhabdomyosarcoma 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Pleural Effusion, Malignant 1Platinum-Resistant Ovarian Carcinoma 1Pancreatic Neoplasms 1

Interventions

aldesleukin 2Trastuzumab 2Pharmaceutical Preparations 2Interleukin-2 2Carboplatin 2Bevacizumab 2tocilizumab 1tipifarnib 1romidepsin 1lipoplatin 1Verteporfin 1Valacyclovir 1Tyrosine Kinase Inhibitors 1Sorafenib 1SPI-77, liposomal 1Povidone-Iodine 1Pleurodesis 1Photochemotherapy 1Paclitaxel 1LMB-100 1Interleukin-12 Subunit p35 1Interleukin-12 1Immunotherapy, Adoptive 1Gemcitabine 1Erlotinib Hydrochloride 1Docetaxel 1Decitabine 1Dasatinib 1Cytoreduction Surgical Procedures 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Pleural Effusion, Malignant × Immunotherapy, Adoptive × Clear all
NCT05268172 2024-05-16

IFN-γ Combined With T Cells in the Treatment of Refractory Malignant Pleural Effusion and Ascites

Affiliated Hospital of Jiangnan University

Phase 1 Unknown
40 enrolled
Thoracic

Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡